Real-time enrollment status for this hematopoietic and lymphatic system neoplasm clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:24 PM UTC
| NCT Number | NCT06279013 |
| Recruiting Status | Recruiting |
| Condition | Hematopoietic and Lymphatic System Neoplasm |
| Phase | NA |
| Target Enrollment | 600 participants |
| Active Locations | 30 sites in the US |
| Sponsor | NRG Oncology |
| Last Updated on CT.gov | September 10, 2026 (Sep 10, 2026) |
As of October 12, 2026: Clinical trial NCT06279013 is currently recruiting participants. This na study for hematopoietic and lymphatic system neoplasm is actively seeking new participants at 30 locations across the United States. The study is sponsored by NRG Oncology. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06279013 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06279013 was last updated Sep 10, 2026 (September 10, 2026). HelloStudys verifies this status automatically.